JN
Johnson & Johnson
JNJ · NYSE
$275.15 -1.18% (-$3.28)
1M +5.13%
Market Cap $663.1B
P/E Ratio 31.52x
Div. Yield 1.90%
ROE 25.74%
Bulios Fair Price
$266.85
3.0% downside
Trenutna cena
$275.15
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price se delnica JNJ trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
31 /100
Expensive P/E 31.52x
P/FCF 35.44x
EV/EBITDA 20.51x
Growth
57 /100
Stable EPS growth 17.90%
Book val. growth 2.02%
Rev. growth 5.60%
Profitability
100 /100
Strong Gross margin 70.45%
FCF margin 19.10%
Net margin 21.48%
Quality
79 /100
Excellent ROIC 13.89%
Asset turnover 0.49x
ROE 25.74%
Debt
81 /100
Low Debt/Equity 0.58x
Net debt/EBITDA 0.85x
Current ratio 1.09x
Stability
47 /100
Moderate Beta 0.24x
Profitable years 6
Rev. volatility 1.15%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o JNJ
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato
Employees
141,700
Headquarters
New Brunswick
Prihajajoči dogodki
13 OKT.
Earnings
Upcoming earnings report